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A B S T R A C T
Many biomedical applications necessitate a targeted intracellular delivery of the nanomaterial to
speciﬁc cells. Therefore, a non-invasive and reliable imaging tool is required to detect both the delivery
and cellular endocytosis of the nanoparticles. Herein, we demonstrate that magneto-photo-acoustic
(MPA) imaging can be used to monitor the delivery and to identify endocytosis of magnetic and optically
absorbing nanoparticles. The relationship between photoacoustic (PA) and magneto-motive ultrasound
(MMUS) signals from the in vitro samples were analyzed to identify the delivery and endocytosis of
nanoparticles. The results indicated that during the delivery of nanoparticles to the vicinity of the cells,
both PA and MMUS signals are almost linearly proportional. However, accumulation of nanoparticles
within the cells leads to nonlinear MMUS-PA relationship, due to non-linear MMUS signal ampliﬁcation.
Therefore, through longitudinal MPA imaging, it is possible to monitor the delivery of nanoparticles and
identify the endocytosis of the nanoparticles by living cells.
 2015 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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With a size of about 100 to 10000 times smaller than human
cells, nanoparticles offer unprecedented potentials to interact with
biomolecules and to revolutionize disease diagnosis and treat-
ment. As an example, nanoparticles have recently attracted
signiﬁcant attention as the vehicle to deliver and release drugs
and therapeutic agents to the disease site [9,28] to achieve highly
localized therapeutic strategies. Such localized therapeutic appli-
cations ultimately necessitate a targeted intracellular delivery and
availability of the nanoparticles to speciﬁc target cells [7,9,28]. The
interaction between nanoparticles and target cells often includes
two steps: delivery and accumulation. During the delivery step, the
nanoparticles (administrated through the blood stream or directly
injected to the site of interest) are delivered to the vicinity of target
cells via different mechanism such as enhanced permeability and
retention (EPR) effect [36]. Second, the delivered nanoparticles* Corresponding author.
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4.0/).accumulate within the target cells through endocytosis, which is
one of the primary membrane translocation mechanisms for
nanoparticles entry into the living cells [15]. Fully understanding
the interactions between nanoparticles and cells is an enormous
advancement towards evaluating the utility of molecularly
targeted nanoparticles in both diagnostic and therapeutic applica-
tions. In an ideal scenario, nanoparticles which are utilized as
biosensors must be activated or generate signal only when they
have entered the cells through endocytosis. However, in real
applications, signals are generated not only from the endocytosed
nanoparticles but also from the nanoparticles in the vicinity of the
cells; and it is extremely difﬁcult to differentiate between these
signals. Most molecular imaging modalities have limited sensitivi-
ty and resolution to speciﬁcally sense the endocytosis of
nanoparticles into living cells mostly due to similar signature of
the obscuring signal generated by the delivered yet not endocy-
tosed nanoparticles [4,43]. Therefore, imaging strategies capable of
detecting nanoparticle delivery and sensing of their intracellular
endocytosis is highly desirable.
Magneto-photo-acoustic (MPA) imaging was developed based
on the integration of ultrasound (US) [6], photoacoustic (PA)
[3,13,27,39,41], and magneto-motive ultrasound (MMUS) [18–
22,26] imaging modalities [11,31–33,35]. By utilizing magneto-
plasmonic nanoparticles as imaging contrast agent, MPA can
provide imaging information at cellular and molecular level with a
high resolution and sensitivity [10,33]. In our previous studies, wele under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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of magnetic nanoparticles generates larger MMUS signals than the
same concentration of isolated nanoparticles [22,23]. Furthermore,
we demonstrated that MPA imaging could differentiate between
the isolated nanoparticles in the vicinity of the cells and the
accumulated nanoparticles within the cells [34]. In MPA imaging,
the amplitude of the PA signal is proportional to the concentration
of optical absorbers, i.e. magneto-plasmonic nanoparticles. Al-
though accumulation of plasmonic metallic nanoparticles could
increase the local heating effect and thus introduces linear and
even nonlinear ampliﬁcation of PA signal in aggregated and
accumulated nanoparticles [25], such phenomenon may not
happen for some types of nanoparticles such as dye-doped
silica-coated magnetic particles [1,24]. On the other hand, when
such nanoparticles are endocytosed, conﬁned in lysosomes, and
form intracellular aggregates with much larger size than isolated
nanoparticles [5,8,12,38], the MMUS signal is ampliﬁed signiﬁ-
cantly. In other words, the MMUS signal from nanoparticles
depends on both the concentration of nanoparticles and their
functional state (i.e., isolated or endocytosed/aggregated)
[22,23]. Therefore, the ratio between MMUS and PA (MMUS/PA)
signals represents the magnetically induced motion from the unit
concentration of nanoparticles. Such ratio, monitored over time,
could identify both the delivery of nanoparticles and endocytosis
of nanoparticles by cells.
Our previous work provided an initial framework for non-
invasive detection of endocytosis of nanoparticles using MPA
imaging [34]. In the current study, we further evaluate the utility of
MPA imaging, coupled with an analytical method, to monitor
nanoparticle delivery and to detect the endocytosis process.
Herein, we propose a longitudinal analysis of MPA signal to
monitor accumulation and endocytosis of nanoparticles within the
cells. To achieve this goal, cell-tissue mimicking phantoms were
designed to closely mimic the realistic in vivo scenario, in which
some of the nanoparticles were endocytosed by the cells of
interest, while the rest of the isolated nanoparticles were present
in the vicinity of the cells. Two in vitro sets of experiments were
designed to simulate the delivery and endocytosis of nanoparticles.
The MPA imaging experiments were performed and the relation-
ship between PA and MMUS signals were analyzed to identify the
delivery and cellular accumulation processes.
2. Materials and Methods
2.1. Synthesis of magnetic nanoparticles as MPA contrast agents
Citrate-capped magnetite (Fe3O4) nanoparticles with optical
absorption at the visible wavelength and large magnetic suscepti-
bility (56 emu/gr Fe) were used as contrast agent in our MPAFig. 1. Transmission electron microscopy (TEM) image of (A) Fe3O4 nanimaging studies. The citrate-capped Fe3O4 nanoparticles were
synthesized through a phase transfer reaction between tri(ethy-
lene glycol)-coated Fe3O4 nanoparticles in ethanol and an aqueous
solution of 14 mg/mL sodium citrate (Sigma-Aldrich) in nano-pure
water [33,37]. The volume ratio between the tri(ethylene glycol)-
coated Fe3O4 solution and the sodium citrate was 1:1. The
tri(ethylene glycol)-coated Fe3O4 nanoparticles were synthesized
by the thermal decomposition of 1 g of iron (III) acetylacetonate
(99.9% trace metals basis, Sigma-Aldrich) in 20 mL tri(ethylene
glycol) (Sigma-Aldrich) at 250 8C for four hours (Maity et al.,
2009). Prior to the phase transfer reaction, the obtained
tri(ethylene glycol)-coated Fe3O4 nanoparticles were cleaned in
0.25 mL batches. A mixture of 0.25 mL Fe3O4 nanoparticles,
0.75 mL ethanol, and 1 mL ethyl acetate was centrifuged at
14,000 g for half an hour. A black NP pellet was obtained after
decanting the supernatant. The cleaning step was repeated three
times, and the obtained pellet of cleaned Fe3O4 nanoparticles was
re-suspended in 0.25 mL ethanol. Then, the desired volumes of
cleaned Fe3O4 nanoparticles in ethanol and the sodium citrate in
water solution were mixed together and shaken at 500 rpm
overnight, allowing the phase transfer reaction. In this reaction, the
Fe3O4 nanoparticles’ tri(ethylene glycol) surface layer was replaced
with citrate ions. The citrate-capped Fe3O4 nanoparticles were
obtained by centrifuging the reaction solution in Millipore 50 kDa
Amicon Ultra-15 Centrifugal Filter Units at 3,000 g for 15 minutes.
The obtained nanoparticles were re-suspended with nano-pure
water and re-ﬁltered four times. Finally the ﬁltered citrate-capped
Fe3O4 nanoparticles were re-suspended in 1  PBS solution. The
size of the synthesized Fe3O4 nanoparticles were measured as
approximately 7.5 nm by using a transmission electron micro-
scope (Fig. 1A). As shown previously, the Fe3O4 nanoparticles
possessed strong optical absorption in visible wavelengths and
high magnetic susceptibility [33]. In this study, the synthesized
SPIO nanoparticles does not show plasmonic effect that can
potentially interfere with hypothesis behind this study. These
contrast agents do not have absorption peak within near infrared
(NIR) region and absorb relatively high at 532 nm. Therefore, PA
imaging experiments were performed at 532 nm wavelength.
2.2. Cell-nanoparticles tissue mimicking phantoms
The macrophages (J774 A1) cells were incubated with citrate-
capped Fe3O4 nanoparticles for 24 hours. Then the harvested
macrophages were washed three times with phosphate buffered
saline (PBS). Cellular uptake, measured using inductively coupled
plasma mass spectrometry (ICP-MS), was approximately 6.7  106
citrate-capped Fe3O4 nanoparticles (7.65 pg Fe3O4 nanoparticles)
per cell. The TEM image of macrophages with endocytosed
nanoparticles is shown in Fig. 1(B).oparticles, (B) macrophages with endocytosed Fe3O4 nanoparticles.
Fig. 2. (A) First phantom with inclusions was designed to mimic delivery of
nanoparticles. Inclusion I was used as control. Other inclusions contained different
concentrations of isolated Fe3O4 nanoparticles. (B) Second phantom was designed
to mimic endocytosis of nanoparticles. Parameter E represented the endocytosis
ratio, which was deﬁned as the ratio of the number of endocytosed nanoparticles to
the total number of nanoparticles in tissue (both endocytosed nanoparticles and
isolated nanoparticles in the vicinity of cells). Inclusions VI to IX mimicked different
portions of nanoparticles were endocytosed by living cells.
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simulate the delivery and endocytosis processes of nanoparticles
(Fig. 2). The background of the tissue-mimicking phantoms was
made out of 3 wt/wt gelatin (300 bloom, Sigma Aldrich, MO, USA).
The inclusions were prepared by mixing 3 wt/wt gelatins with
Fe3O4 nanoparticles at different concentrations or functional states
(i.e., endocytosed Fe3O4 nanoparticles, isolated nanoparticles, or
mixture of both). In the ﬁrst phantom, inclusions I to V contained
non-labeled cells mixed with different concentrations of isolated
Fe3O4 nanoparticles, mimicking NP delivery into tissues. Inclusion I
contained macrophage cells only and served as control; the
remaining inclusions contained 0.2 mg/mL (inclusion II), 0.4 mg/
mL (inclusion III), 0.67 mg/mL (inclusion IV), and 1 mg/mL
(inclusion V) Fe3O4 nanoparticles mixed with cells.Fig. 3. Magneto-photo-acoustic (MPA) imaging system block diagram inThe second phantom was made to simulate the endocytosis
process. The endocytosis process can be considered as a two-stage
process. In the ﬁrst stage, the nanoparticles are delivered to the
vicinity of cells and then in second stage, they are endocytosed by
the cells. To simulate this process, two set of cells were prepared:
(a) cells loaded with nanoparticles, and (b) intact (unloaded) cells.
Knowing the average number of nanoparticles in loaded cells
(through ICP-MS measurements), four inclusions were made out of
gelatin and mixture of nanoparticles and magnetically labeled
cells. While the concentration of magnetite nanoparticles was kept
the same in all four inclusions, the ratio between the endocytosed
nanoparticles (contained in labeled cells) and the isolated
nanoparticles was different. For example, in phantom VI, 25% of
total nanoparticles were within the loaded cells, and the rest were
simply mixed with intact cells. Therefore, inclusions XI to IX have
the same number or concentration of nanoparticles as well as the
same number of cells. However, the portion of nanoparticles
within the cells and mixed with the cells were changed. The
different ratios mimicked the cellular uptake of nanoparticles by
living cells in vivo. The parameter E in Fig. 2(B) represents the
percentage of endocytosis and deﬁned as:
E ¼ Number o f endocytosed nano particles
Total number o f nano particlesðendocytosed þ isolatedÞ  100%
The total number of Fe3O4 nanoparticles within the inclusions
include both endocytosed nanoparticles inside cells and isolated
nanoparticles in the vicinity of cells. The increase of E indicates the
larger uptake of nanoparticles by the macrophage cells. Parameter
E was precisely controlled and varied between 25% to 100% with an
increment of 25%. As a result, inclusions VI, VII, VIII, and IX contain
25%, 50%, 75%, and 100% of nanoparticles in endocytosed functional
state. To eliminate any experimental dependent variation in MPA
measurements, an identical number of macrophage cells
(3.75  106 cells) was embedded in all inclusions. In addition,
0.2 wt% of 30 mm silica particles, acting as ultrasound scatters, was
added to the inclusions.
2.3. MPA imaging
To evaluate the ability of MPA imaging to assess nanoparticles
endocytosis process, MPA imaging system shown in Fig. 3 was used
to image tissue-mimicking phantoms. Samples were placed in a
water cuvette that was attached to a 3D positioning stage. The lasercluding ultrasound pulser/receiver, laser and magnetic excitation.
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Physics) laser system (4002600 nm wavelength range, 57 ns
pulse duration, up to 10 Hz pulse repetition frequency). The pulsed
laser light at 532 nm wavelength was delivered to the samples
through a 1500 mm diameter optical ﬁber. The ﬂuence of the laser
was measured as 10 mJ/cm2 with power meter (Nova II, Ophir Ltd.,
Jerusalem, Israel). A single-element focused US transducer
(25 MHz center frequency, bandwidths of about 50%, 25.4 mm
focal depth, f-number of 4, Olympus-NDT, Waltham, MA, USA) was
used for pulse-echo US imaging as well as for PA signal detection.
The imaging sequence was set as following. First, the PA signal is
generated and detected by the US transduce. After a delay of 30 ms,
US pulse was sent to the sample and the backscattered US echo
signal was detected to form US image. Then a pulsed magnetic ﬁeld
with 20 ms pulse duration was applied from the bottom of the
sample through a solenoid with a cone-shaped-tip core to focus the
ﬁeld to induce the magneto-motive displacement. The magnetic
ﬂux density (B) was measured as 0.8 T at the tip of a cone shaped
core embedded within the coil by using a digital Gaussmeter (DSP
475, Lakeshore Crytronics, OH, USA). The air gap between the
water tank and iron core tip was about 1 mm to avoid any direct
contact between the sample and magnetic ﬁeld generator. The US
pulse-echo signals were acquired to track the magnetically
induced displacement from the sample. The repetition rate of
the US pulses sent to the sample was 1 kHz. A total of 100 pulse-
echoes (100 ms) were acquired for the displacement tracking, in
which 20 pulse-echoes (20 ms) were measured before the
application of the magnetic ﬁeld and used as the static reference
of motion detection. After the magnetic excitation, 80 pulse-echo
signals over 80 ms time interval were acquired to track the
magnetically induced. At each data point, the temporal behavior of
the displacement was calculated by estimating the cross-correla-
tion between the static signal and the signals acquired after the
magnetic ﬁeld application [17]. The maximum measured displace-
ment was used to form MMUS image. A custom-built LabVIEW
(National Instruments, TX, USA) application was used to control
the mechanical scanning to provide spatially co-registered US, PA
and MMUS images.
The US, PA and MMUS images of inclusions within each tissue-
mimicking phantom were reconstructed and spatially co-regis-
tered. To further analyze the ability of MPA imaging to detect the
delivery of nanoparticles and endocytosis, the regions of interest of
the same size were selected within each inclusion. The amplitude
of PA and MMUS signal was averaged within each region of
interest. Then the PA signal was plotted versus MMUS signal forFig. 4. (A) US images of the inclusions within the delivery-mimicking phantom. Each im
region marked with yellow semicircle and the concentration of Fe3O4 nanoparticles. (C) R
rectangle and the concentration of Fe3O4 nanoparticles. (D) Relationship between MMeach inclusions, and the realationship between both signals was
studied. Speciﬁcally, based on the linear ﬁtting, the slopes of PA-
MMUS curves for the inclusions within phantoms were compared
to indicate the processes of delivery and celluar endocytosis.
3. Results and Discussion
The US images of the ﬁrst phantom, which mimicked the
delivery of nanoparticles to the vicinity of cells, are shown in
Fig. 4(A). The averaged amplitude of the PA signal from each
inclusion (marked with yellow semicircle) is displayed in Fig. 4B.
The error bars in Fig. 4B show the standard deviation of the PA
signal magnitude from multiple measurements. There was no
signiﬁcant PA signal detected from inclusion I, which did not
contain any Fe3O4 nanoparticles and was used as a control. The PA
signals from inclusions II to V indicate that the amplitude of PA
signals increased proportional to the concentration of nanopar-
ticles. This result is consistent with the linear dependence of PA
signals on the concentration of nanoparticles (gold nanorods)
shown in previous studies [34]. The magnetically induced
displacement was measured from the regions outlined with red
rectangle (1000 mm axially and 500 mm laterally) in each
inclusion. The mean and standard deviation of MMUS signal from
each inclusion are displayed in Fig. 4C. As the concentration of
nanoparticles increases, the magnetically induced displacement
increases. Finally, the relationship between PA and MMUS signals
is shown in Fig. 4D. In Fig. 4D, the PA signal amplitude is shown in
vertical axis, while the amplitude of MMUS signal is shown in
horizontal axis. The ﬁtting curve of PA-MMUS plot indicates the
linear relationship between PA and MMUS signals for the isolated
nanoparticles. In other words, when the nanoparticles are
delivered into the tissue, both PA and MMUS signal showed a
monotonic increase with respect to the concentration of nano-
particles. Therefore, a positive slope of PA-MMUS curve was
associated with the delivery process.
The US images of the inclusions in second phantom, which
mimicked the endocytosis of nanoparticles by the living cells, are
shown in Fig. 5(A). Four inclusions contained the same concentra-
tion of Fe3O4 nanoparticles (0.67 mg/mL) with different endocyto-
sis ratio E. The E value for inclusions VI, VII, VIII, and IX was 25%,
50%, 75%, and 100%, respectively. Similar to the previous phantom,
PA and MMUS signals, as well as their ratio for different inclusions,
were measured and analyzed (Fig. 5B-D). PA signals from all the
inclusions were approximately the same, which was expected
given the same concentration of nanoparticles in all inclusionsage is 8.09 mm axially. (B) Relationship between the PA signal amplitude from the
elationship between the MMUS signal amplitude from the regions marked with red
US signals and PA signals as Fe3O4 nanoparticles were delivered into tissues.
Fig. 5. (A) US images of the inclusions within the endocytosis-mimicking phantom. (B) The relationship between the PA signal amplitude from the region marked with yellow
semicircle and the endocytosis ratio E of Fe3O4 nanoparticles. (C) The relationship between the MMUS signal amplitude from the regions marked with red rectangle and
endocytosis ratio E of Fe3O4 nanoparticles. (D) The relationship between MMUS signals and PA signals as Fe3O4 nanoparticles were endocytosed by living cells.
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induced displacement) increased signiﬁcantly when E value was
larger, indicating more nanoparticles entered into cells. Thus
MMUS signal was sensitive to the endocytosis process (Fig. 5C).
Finally the relationship between PA and MMUS signals (Fig. 5D)
shows a different trend compared to the delivery process. As more
Fe3O4 nanoparticles were endocytosed, the PA signal remained
constant while the MMUS signal increased. Therefore, the slope of
the PA – MMUS curve was zero during the endocytosis process.
The results shown in Figures 4 and 5 suggest that MPA imaging
is capable of monitoring the delivery and intracellular endocytosis
of nanoparticles. During the nanoparticles’ delivery, the concen-
tration of nanoparticles increases, and both PA and MMUS signals
increase linearly. Thus a linear relationship between PA and MMUS
signals was observed (Fig. 4D). In the process of nanoparticles’
endocytosis, assuming the concentration of nanoparticles remains
constant, PA signal is relatively constant, while the MMUS signal is
ampliﬁed due to the aggregation of endocytosed nanoparticles
within the endosomes [5,8,12,22,34,38]. Thus the slope of PA-
MMUS curve is zero for endocytosis process. Therefore, nanopar-
ticles’ delivery and endocytosis can be detected by investigating
the relationship between PA and MMUS signals. Such ability of
MPA imaging could be advantageous for several biomedical
applications of nanoparticles such as drug delivery [14], cancer
therapy [29], biosensors [16].
From above results, at the same concentration of nanoparticles,
the amplitude of MMUS signal is directly related to the ratio of
endocytosed nanoparticles. In MMUS imaging, the magneto-
motive force (F) acting on a magnetic NP that causing the
displacement can be expressed as
FðZÞ ¼ Vn p f mxn p
m0
BZ
@BZ
@z
(1)
where Vnp is the total size of the NP, fm is a dimensionless factor
that represents the volumetric ratio of magnetic material in a NP, z
is the direction along the magnetic ﬁeld, m0 is vacuum
permeability, Bz is magnetic ﬂux density, and xnp is the volume
magnetic susceptibility of the NP. From Equation (1), the induced
MMUS signal is proportional to the magnetic susceptibility of the
NPs. For dilute solution of magnetic particles, the magnetic
susceptibility is proportional to particle concentration [2] Howev-
er, as particle concentration increases, the magnetic susceptibility
increases faster than linear dependence due to the interactionbetween the particles [30]. Especially, when aggregates were
formed, a signiﬁcant non-linear ampliﬁcation was observed in
magnetic susceptibility, resulting in larger MMUS signals
[22]. MMUS imaging is sensitive to detect aggregations containing
several Fe3O4 NPs [22]. When nanoparticles were endocytosed by
the cells, the aggregates, formed within lysosomal bodies, contain
several to tens of nanoparticles [5,8,12,38] (Fig. 1). The interaction
between the Fe3O4 NPs in the aggregate resulted in larger
susceptibility and increased MMUS signals. Therefore, the larger
magnetically induced displacement from the endocytosed NPs
compared to that from the same concentration of isolated NPs is
due to the interaction between magnetic NPs.
Longitudinal MPA imaging has the potential to monitor the
delivery and endocytosis of nanoparticles in vivo. When nano-
particles are injected locally or systemically, they will accumulate
in the site of interest and be present in the vicinity of the cells at
ﬁrst, Then the NPs will be endocytosed by the cells and form
aggregates in membrane vesicles. The analysis of PA-MMUS curve
over time is indicative of each stage of the process. When the
nanoparticles start accumulating, the PA-MMUS curve would
exhibit a positive slope, considering the dependence of both PA and
MMUS signals on the concentration of nanoparticles. When certain
amount of nanoparticles is accumulated, some of them enter into
the cells through endocytic process, and the MMUS signal would
increase nonlinearly. Thus, the slope of PA-MMUS will reduce.
Finally, when a delivery equilibrium is achieved, the concentration
of nanparticles in the region of interest will not change while more
nanoparticles will be endocytosed by the cells. In tis case, the PA
signal will be constant, while the MMUS signal will keep increasing
due to stronger MMUS response from the endocytosed nanopar-
ticles. Thus the PA-MMUS curve will have a zero slope for this
stage. Therefore, without a prior information, longitunal MPA
imaging along should be able to monitor the delivery and
endocytosis processes non-invasively in vivo.
In the current in vitro study, Fe3O4 nanoparticles were used as
contrast agent for both PA and MMUS imaging, given their
biocompatibility and availability, to investigate the interaction
between nanoparticles with macrophage cells. For further
advanced applications, magneto-plasmonic nanoconstructs could
be used as contrast agents for the MPA imaging [40,42]. Coupling
with the capability of MPA imaging to sense endocytosed
nanoparticles, the dual-contrast nanoparticles could be used as
biosensors in living cells.
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In conclusion, this study demonstrated that the delivery and
cellular endocytosis of nanoparticles can be noninvasively sensed
by MPA imaging. In MPA imaging, the relationship between PA and
MMUS signals was analyzed to be indicative of the functional
processes of nanoparticles in tissue. When the nanoparticles were
delivered into tissue, both PA and MMUS signals increased linearly
to the NP concentration. On the other hand, when the nanopar-
ticles entered into living cells based on endocytosis, the PA signal
remained relatively constant while the MMUS signal was
ampliﬁed. Therefore, the slope of MMUS-PA curve can provide
information on the delivery and endocytosis processes of the
nanoparticles.
Conﬂict of interest
The authors declare that there are no conﬂicts of interest.
Acknowledgements
The authors are grateful to Dr. Dwight K. Romanovicz from
Institute for Cellular and Molecular Biology at the University of
Texas at Austin for his help with transmission electron microscopy
of cells, and to Mr. Ryan Truby of the University of Texas at Austin
(currently at Harvard University) for synthesis of the magnetite
nanoparticles. This work was partially supported by the National
Institutes of Health under grant EB 008821.
References
[1] C.L. Bayer, Y.-S. Chen, S. Kim, S. Mallidi, K. Sokolov, S. Emelianov, Multiplex
photoacoustic molecular imaging using targeted silica-coated gold nanorods,
Biomedical Optics Express 2 (2011) 1828–1835.
[2] B. Berkovsky, V.F. Medvedev, M.S. Krakov, Magnetic ﬂuids, Oxford University
Press, 1993.
[3] T. Bowen, R. Nasoni, A. Pifer, G. Sembroski, Some experimental results on the
thermoacoustic imaging of tissue equivalent phantom materials, Ultrasonics
Symposium (1981) 823–827.
[4] W. Cai, X. Chen, Nanoplatforms for targeted molecular imaging in living
subjects, Small 3 (2007) 1840–1854.
[5] B.D. Chithrani, W.C. Chan, Elucidating the mechanism of cellular uptake and
removal of protein-coated gold nanoparticles of different sizes and shapes,
Nano Letters 7 (2007) 1542–1550.
[6] F.S. Foster, G. Lockwood, L. Ryan, K. Harasiewicz, L. Berube, A. Rauth, Principles
and applications of ultrasound backscatter microscopy IEEE Transactions on
Ultrasonics, Ferroelectrics and Frequency Control 40 (1993) 608–617.
[7] J. Gao, B. Xu, Applications of nanomaterials inside cells, Nano Today 4 (2009)
37–51.
[8] A.K. Gupta, A.S. Curtis, Surface modiﬁed superparamagnetic nanoparticles for
drug delivery: interaction studies with human ﬁbroblasts in culture, Journal of
Materials Science: Materials in Medicine 15 (2004) 493–496.
[9] X. Huang, I.H. El-Sayed, W. Qian, M.A. El-Sayed, Cancer cell imaging and
photothermal therapy in the near-infrared region by using gold nanorods, J.
Am. Chem. Soc 128 (2006) 2115–2120.
[10] Y. Jin, C. Jia, S.-W. Huang, M. O’Donnell, X. Gao, Multifunctional nanoparticles
as coupled contrast agents, Nature communications 1 (2010) 41.
[11] Y. Jin, C. Jia, S.W. Huang, M. O’Donnell, X. Gao, Multifunctional nanoparticles
as coupled contrast agents, Nature Communications 1 (2010) 1–8.
[12] J. Kneipp, H. Kneipp, M. McLaughlin, D. Brown, K. Kneipp, In vivo molecular
probing of cellular compartments with gold nanoparticles and nanoaggregates,
Nano Letters 6 (2006) 2225–2231.
[13] R.A. Kruger, P. Liu, Photoacoustic ultrasound: pulse production and detection
in 0.5% liposyn, Medical physics 21 (1994) 1179.
[14] L. Hu, W. Mao Z, C.Y. Gao, Colloidal particles for cellular uptake and delivery, J
Mater Chem 19 (2009) 3108–3115.
[15] R. Le´vy, U. Shaheen, Y. Cesbron, V. Se´e, Gold nanoparticles delivery in
mammalian live cells: a critical review, Nano Reviews 1 (2010) 1–18.
[16] H. Lord, S.O. Kelley, Nanomaterials for ultrasensitive electrochemical nucleic
acids biosensing, J Mater Chem 19 (2009) 3127–3134.
[17] M. Lubinski, S. Emelianov, M. O’Donnell, Speckle tracking methods for
ultrasonic elasticity imaging using short-time correlation IEEE Transactions on
Ultrasonics, Ferroelectrics and Frequency Control 46 (2002) 82–96.
[18] M. Mehrmohammadi, J. Oh, S.R. Aglyamov, A.B. Karpiouk, S.Y. Emelianov,
Pulsed magneto-acoustic imaging: IEEE (2009) 4771–4774.
[19] M. Mehrmohammadi, J. Oh, L. Ma, E. Yantsen, T. Larson, S. Mallidi, S. Park, K.P.
Johnston, K. Sokolov, T. Milner, S. Emelianov, Imaging of iron oxidenanoparticles using magneto-motive ultrasound, IEEE Ultrasonics Symposium
(2007) 652–655.
[20] M. Mehrmohammadi, J. Oh, S. Mallidi, S.Y. Emelianov, Pulsed magneto-motive
ultrasound imaging using ultrasmall magnetic nanoprobes, Molecular imaging
10 (2011) 102.
[21] M. Mehrmohammadi, T.-H. Shin, M. Qu, P. Kruizinga, R.L. Truby, J.-H. Lee, J.
Cheon, S.Y. Emelianov, In vivo pulsed magneto-motive ultrasound imaging
using high-performance magnetoactive contrast nanoage, Nanoscale 5 (2013)
11179–11186.
[22] M. Mehrmohammadi, K. Yoon, M. Qu, K. Johnston, S. Emelianov, Enhanced
pulsed magneto-motive ultrasound imaging using superparamagnetic
nanoclusters, Nanotechnology 22 (2011) 045502.
[23] M. Mehrmohammadi, K.Y. Yoon, M. Qu, K.O. Johnston, S.Y. Emelianov, On
application of magnetic nanoclusters to improve the sensitivity of pulsed
magnetomotive ultrasound imaging, Ultrasonics Symposium (IUS), 2010 IEEE
(2010) 241–244.
[24] S.Y. Nam, L.M. Ricles, L.J. Suggs, S.Y. Emelianov, In vivo ultrasound and
photoacoustic monitoring of mesenchymal stem cells labeled with gold
nanotracers, PLoS One 7 (2012) e37267.
[25] S.Y. Nam, L.M. Ricles, L.J. Suggs, S.Y. Emelianov, Nonlinear photoacoustic signal
increase from endocytosis of gold nanoparticles, Optics letters 37 (2012)
4708–4710.
[26] J. Oh, M.D. Feldman, J. Kim, C. Condit, S. Emelianov, T.E. Milner, Detection of
magnetic nanoparticles in tissue using magneto-motive ultrasound,
Nanotechnology 17 (2006) 4183–4190.
[27] A.A. Oraevsky, S.L. Jacques, R.O. Esenaliev, F.K. Tittel, Laser-based optoacoustic
imaging in biological tissues, Proc SPIE 2134 (1994) 122.
[28] J. Panyam, V. Labhasetwar, Biodegradable nanoparticles for drug and gene
delivery to cells and tissue, Advanced Drug Delivery Reviews 55 (2003) 329–
347.
[29] D. Peer, J.M. Karp, S. Hong, O.C. FaroKhzad, R. Margalit, R. Langer, Nanocarriers
as an emerging platform for cancer therapy, Nat Nanotechnol 2 (2007) 751–
760.
[30] A. Pshenichnikov, Equilibrium magnetization of concentrated ferrocolloids,
Journal of magnetism and magnetic materials 145 (1995) 319–326.
[31] M. Qu, S. Kim, M. Mehrmohammadi, S. Mallidi, P. Joshi, K. Homan, Y.S. Chen, S.
Emelianov, Combined photoacoustic and magneto-motive ultrasound imaging
7564 (2010) 756433–756441.
[32] M. Qu, S. Mallidi, M. Mehrmohammadi, L.L. Ma, K.P. Johnston, K. Sokolov, S.
Emelianov, Combined photoacoustic and magneto-acoustic imaging: IEEE
(2009) 4763–4766.
[33] M. Qu, S. Mallidi, M. Mehrmohammadi, R. Truby, K. Homan, P. Joshi, Y.S. Chen,
K. Sokolov, S. Emelianov, Magneto-photo-acoustic imaging, Biomed Opt.
Express 2 (2011) 385–395.
[34] M. Qu, M. Mehrmohammadi, S. Emelianov, Detection of nanoparticle
endocytosis using magneto-photoacoustic imaging, Small 7 (2011) 2858–2862.
[35] M. Qu, M. Mehrmohammadi, R. Truby, I. Graf, K. Homan, S. Emelianov,
Contrast-enhanced magneto-photo-acoustic imaging in vivo using dual-
contrast nanoparticles, Photoacoustics 2 (2014) 55–62.
[36] E. Ruoslahti, S.N. Bhatia, M.J. Sailor, Targeting of drugs and nanoparticles to
tumors, The Journal of cell biology 188 (2010) 759–768.
[37] R.L. Truby, K.A. Homan, M. Qu, M. Mehrmohammadi, S. Emelianov, Synthesis
of a hybrid plasmonic-superparamagnetic contrast agent for magneto-photo-
acoustic imaging, Biomecial Engineering Society Annual Meeting (2010).
[38] A. Verma, F. Stellacci, Effect of surface properties on nanoparticle–cell
interactions, Small 6 (2010) 12–21.
[39] B. Wang, E. Yantsen, T. Larson, A.B. Karpiouk, S. Sethuraman, J.L. Su, K.
Sokolov, S.Y. Emelianov, Plasmonic intravascular photoacoustic imaging for
detection of macrophages in atherosclerotic plaques, Nano Letters 9 (2009)
2212–2217.
[40] C. Wang, J. Chen, T. Talavage, J. Irudayaraj, Gold nanorod/Fe3O4 nanoparticle
‘‘nano-pearl-necklaces’’ for simultaneous targeting, dual-mode imaging, and
photothermal ablation of cancer cells, Angewandte Chemie 121 (2009) 2797–
2801.
[41] X. Wang, Y. Pang, G. Ku, X. Xie, G. Stoica, L.V. Wang, Noninvasive laser-
induced photoacoustic tomography for structural and functional in vivo
imaging of the brain, Nature Biotechnology 21 (2003) 803–806.
[42] Q. Wei, H.M. Song, A.P. Leonov, J.A. Hale, D. Oh, Q.K. Ong, K. Ritchie, A. Wei,
Gyromagnetic imaging: dynamic optical contrast using gold nanostars with
magnetic cores, Journal of the American Chemical Society 131 (2009) 9728–
9734.
[43] R. Weissleder, M.J. Pittet, Imaging in the era of molecular oncology, Nature
452 (2008) 580–589.
Min Qu received her B.S. and M.S. degrees in Electrical
Engineering at Nanjing University in China, in
2005 and 2008, respectively. She received her Ph.D.
degree in Biomedical Engineering at the University of
Texas at Austin in TX in 2011. She is currently an
applied research engineer in Biotronik Inc. in Portland,
OR. Her research interests include ultrasound-based
hybrid imaging technique, sensing functional process-
es of nanoparticles, and remote communication of
implanted devices.
M. Qu et al. / PhotoacoustiMohammad Mehrmohammadi received his B.S. and
M.S. degree in Electrical Engineering from Sharif
University of Technology (Iran) and Illinois Institute
of Technology (Chicago, IL) respectively. He received his
Ph.D. degree in Biomedical Engineering at the Univer-
sity of Texas at Austin and worked as a senior research
fellow at Mayo Clinic in Rochester, Minnesota. He is
currently an Assistant Professor of Biomedical Engi-
neering at Wayne State University (Detroit, Michigan).
His research interests include pre-clinical and clinical
ultrasound-based molecular imaging modalities in-
cluding Photoacoustic and Magneto-motive Ultrasound
Imaging as well as ultrasound tissue elastography.Stanislav Emelianov received his B.S. and M.S. degrees
in physics and acoustics in 1986 and 1989, respectively,
and Ph.D. degree in physics in 1993 from Moscow State
University, Russia. He is currently a Professor in the
Department of Biomedical Engineering at The Univer-
sity of Texas at Austin in Austin, TX, and an
AdjunctProfessor at the University of Texas M.D.
Anderson Cancer Center in Houston, TX. His research
interests include molecular imaging, photoacoustic
imaging, elasticity imaging, functional imaging, tissue
differentiation, image-guided therapy, and contrast
agents including various nanoconstructs.
cs 3 (2015) 107–113 113
